A novel antifungal antibiotic, YM-193221, was found in the culture broth of a fungus, Pseudallescheria ellipsoidea. The structure of the antibiotic was determined through several spectroscopic experiments as 2-dimethylamino-1-(4-hydroxyphenyl)-8,10-dimethyl-6-dodecene-3-one. YM-193221 exhibited potent antifungal activity against Candida albicans and also inhibited mannan synthesis in the yeast cell wall.
Opportunistic infections caused by pathogenic fungi such as Candida albicans, Cryptococcus neoformans and Aspergillus fumigates have increased recently and become a serious problem. Patients with compromised immune systems, those who receive organ transplants and cancer chemotherapy, and those infected by the human immunodeficiency virus (HIV), are particularly prone to such infections1). Although fluconazole is one of the most commonly used antifungal agents, the isolation of fluconazole-resistant strain of Candida albicans has been reported2). In light of this, new antifungal agents with a different mechanism of action have been sought extensively.
Mannan is a yeast glycoprotein with a high mannose content, and one of the major cell wall components3). Mannan is involved in the pathogenicity and adherance of the pathogenic fungi Candida albicans4,5), Cryptococcus neoformans6,7), and Aspergillus fumigatus8,9 1H NMR spectra and 13C NMR spectra of YM-193221 were recorded at 500MHz and 12.5MHz in CDCl3, respectively. The proton resonance multiplicity and coupling constant (J= Hz) are in parenthesis. 
